Free Trial
→ Man Who Called Nvidia at $1.10 Says Buy This Now... (From The Oxford Club) (Ad) Free LENZ Stock Alerts

LENZ Therapeutics (LENZ) SEC Filings & 10K Form

LENZ Therapeutics logo
$29.96 +0.19 (+0.64%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$30.10 +0.14 (+0.47%)
As of 08/1/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent LENZ Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/30/2025
7:03 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
3:50 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
3:50 PM		LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SCHEDULE 13D/A
07/01/2025
5:16 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
4:50 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:49 PM		LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SCHEDULE 13D/A
06/11/2025
6:43 PM		Kolchinsky Peter (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:45 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Scheiner Zachary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:46 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:46 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:46 PM		Guerard Frederic (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:46 PM		Drapkin Kimberlee C (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:46 PM		George Jeffrey P. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
3:19 PM		LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13D/A
05/07/2025
3:16 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
3:36 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form ARS
04/28/2025
3:30 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form DEF 14A
04/28/2025
3:33 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form DEFA14A
04/15/2025
7:37 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2025
11:15 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/14/2025
11:15 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/09/2025
6:20 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:05 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
04/09/2025
3:06 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
04/08/2025
11:15 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/08/2025
11:15 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/04/2025
3:45 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form POS AM
04/04/2025
3:46 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form POS AM
04/04/2025
3:48 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/04/2025
3:53 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/19/2025
3:45 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/19/2025
3:38 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
5:10 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:26 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:20 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:22 PM		Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:24 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
6:55 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:08 PM		LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
11/06/2024
7:03 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
11/06/2024
7:06 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
Is America’s Everything Bubble About to Burst? (Ad)

On July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushing America’s debt-to-GDP ratio to 175%. Top investors are warning of an epic bubble bursting soon. A free guide reveals how to shield your 401(k), savings, and portfolio before the collapse.

Claim your FREE Big Beautiful Bubble Survival Guide now
11/06/2024
6:35 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:26 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
7:23 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
10/28/2024
7:24 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
10/28/2024
7:09 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
11:15 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
09/19/2024
4:04 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
09/11/2024
3:09 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/14/2024
3:25 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
08/12/2024
7:05 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:11 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:LENZ) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift
Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...
Stansberry Research | Sponsored
I’d rather trade news like this than gamble on hype
Real traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...
Timothy Sykes | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Investigating the Most Controversial Stock on Earth
Tesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...
Brownstone Research | Sponsored
This New Rule Could Change Everything
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...
American Alternative | Sponsored
Sell these "safe" blue chips immediately
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...
InvestorPlace | Sponsored